Cargando…

Nanomaterials as Inhibitors of Epithelial Mesenchymal Transition in Cancer Treatment

Epithelial-mesenchymal transition (EMT) has emerged as a key regulator of cell invasion and metastasis in cancers. Besides the acquisition of migratory/invasive abilities, the EMT process is tightly connected with the generation of cancer stem cells (CSCs), thus contributing to chemoresistance. Howe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cordani, Marco, Strippoli, Raffaele, Somoza, Álvaro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017008/ https://www.ncbi.nlm.nih.gov/pubmed/31861725 http://dx.doi.org/10.3390/cancers12010025

Ejemplares similares

Nanomaterials for Autophagy-Related miRNA-34a Delivery in Cancer Treatment
por: Sharma, Priyanka, et al.
Publicado: (2020)

Editorial: Autophagy modulation in cancer treatment utilizing nanomaterials and nanocarriers
por: Cordani, Marco, et al.
Publicado: (2023)

Targeting autophagy using metallic nanoparticles: a promising strategy for cancer treatment
por: Cordani, Marco, et al.
Publicado: (2018)

Editorial: New Approaches to Tackle EMT and Fibrosis: From Epigenetics to Nanotechnology
por: Battistelli, Cecilia, et al.
Publicado: (2021)

Editorial: Novel Cancer Treatments Based on Autophagy Modulation
por: Cordani, Marco, et al.
Publicado: (2021)

Sestrins as a Therapeutic Bridge between ROS and Autophagy in Cancer
por: Sánchez-Álvarez, Miguel, et al.
Publicado: (2019)

SYNCRIP Modulates the Epithelial-Mesenchymal Transition in Hepatocytes and HCC Cells
por: Riccioni, Veronica, et al.
Publicado: (2022)

Modified Gold Nanoparticles to Overcome the Chemoresistance to Gemcitabine in Mutant p53 Cancer Cells
por: García-Garrido, Eduardo, et al.
Publicado: (2021)

Epithelial-mesenchymal transition in prostate cancer: an overview
por: Montanari, Micaela, et al.
Publicado: (2017)

Autophagy and the Lysosomal System in Cancer
por: Kumar, Suresh, et al.
Publicado: (2021)

Sirtuins and Cancer: Role in the Epithelial-Mesenchymal Transition
por: Palmirotta, Raffaele, et al.
Publicado: (2016)

Editorial: Molecular Mechanisms and New Therapeutic Targets in Epithelial to Mesenchymal Transition (EMT) and Fibrosis
por: Battistelli, Cecilia, et al.
Publicado: (2020)

Editorial: Molecular mechanisms and new therapeutic targets in epithelial to mesenchymal transition (EMT) and fibrosis, volume II
por: Battistelli, Cecilia, et al.
Publicado: (2022)

Sestrins at the Interface of ROS Control and Autophagy Regulation in Health and Disease
por: Cordani, Marco, et al.
Publicado: (2019)

Epithelial to mesenchymal transition and breast cancer
por: Tomaskovic-Crook, Eva, et al.
Publicado: (2009)

Epithelial-Mesenchymal Transition and Breast Cancer
por: Wu, Yanyuan, et al.
Publicado: (2016)

Epithelial-mesenchymal transition, cancer stem cells and treatment resistance
por: Dave, Bhuvanesh, et al.
Publicado: (2012)

The Roles of Epithelial-to-Mesenchymal Transition (EMT) and Mesenchymal-to-Epithelial Transition (MET) in Breast Cancer Bone Metastasis: Potential Targets for Prevention and Treatment
por: Demirkan, Binnaz
Publicado: (2013)

Interplay between ROS and Autophagy in Cancer and Aging: From Molecular Mechanisms to Novel Therapeutic Approaches
por: Cordani, Marco, et al.
Publicado: (2019)

Narrative review: mesenchymal-epithelial transition inhibitors—meeting their target
por: Safi, Danish, et al.
Publicado: (2021)

TGFβ Impairs HNF1α Functional Activity in Epithelial-to-Mesenchymal Transition Interfering With the Recruitment of CBP/p300 Acetyltransferases
por: Bisceglia, Francesca, et al.
Publicado: (2019)

Role of Epithelial to Mesenchymal Transition in Colorectal Cancer
por: Lu, Jian, et al.
Publicado: (2023)

Nanomedicine for autophagy modulation in cancer therapy: a clinical perspective
por: López-Méndez, Tania B., et al.
Publicado: (2023)

Targeting met mediated epithelial-mesenchymal transition in the treatment of breast cancer
por: Sylvester, Paul W
Publicado: (2014)

Glycobiology of the Epithelial to Mesenchymal Transition
por: Pucci, Michela, et al.
Publicado: (2021)

Post-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions
por: Guo, Fei, et al.
Publicado: (2014)

Epithelial–Mesenchymal Transition in the Pathogenesis of Idiopathic Pulmonary Fibrosis
por: Salton, Francesco, et al.
Publicado: (2019)

Long Noncoding RNA and Epithelial Mesenchymal Transition in Cancer
por: Gugnoni, Mila, et al.
Publicado: (2019)

Estrogen Receptors in Epithelial-Mesenchymal Transition of Prostate Cancer
por: Di Zazzo, Erika, et al.
Publicado: (2019)

Epithelial-mesenchymal transition in breast cancer progression and metastasis
por: Wang, Yifan, et al.
Publicado: (2011)

Contribution of Epithelial-Mesenchymal Transition to Pancreatic Cancer Progression
por: Krantz, Seth B., et al.
Publicado: (2010)

Autophagy and epithelial–mesenchymal transition: an intricate interplay in cancer
por: Gugnoni, Mila, et al.
Publicado: (2016)

MicroRNAs and epithelial-mesenchymal transition in prostate cancer
por: Sekhon, Kirandeep, et al.
Publicado: (2016)

Epigenetic Regulation of the Epithelial to Mesenchymal Transition in Lung Cancer
por: Roche, Joëlle, et al.
Publicado: (2017)

Epithelial-to-Mesenchymal Transition and MicroRNAs in Lung Cancer
por: Legras, Antoine, et al.
Publicado: (2017)

E-cadherin on epithelial–mesenchymal transition in thyroid cancer
por: Zhu, Xiaoyu, et al.
Publicado: (2021)

Stromal-Modulated Epithelial-to-Mesenchymal Transition in Cancer Cells
por: Atiya, Huda I., et al.
Publicado: (2023)

The Epithelial-to-Mesenchymal Transition in Cancer
por: Roche, Joëlle
Publicado: (2018)

Epithelial–mesenchymal transition in cancer
por: Moustakas, Aristidis, et al.
Publicado: (2017)

Metabolic Plasticity and Epithelial-Mesenchymal Transition
por: Thomson, Timothy M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5gqmc972pbt5its1st1qim0om8